Sub-second neurochemistry of error signals and affective processing in depression
抑郁症中错误信号和情感处理的亚秒神经化学
基本信息
- 批准号:10453962
- 负责人:
- 金额:$ 75.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AffectiveAnhedoniaAnteriorBiologicalBrain regionChemicalsClinicClinicalCognitionComputer softwareConflict (Psychology)Decision MakingDiseaseDopamineElectrochemistryElectrodesEmotionalEpilepsyFoundationsFunctional disorderFutureGoalsHospitalsHumanImpairmentImplanted ElectrodesIndividualInvestigationLearningMajor Depressive DisorderMeasuresMedicalMental DepressionMethodsMonitorMoodsNeuromodulatorNeurotransmittersParticipantPharmaceutical PreparationsPhasePositron-Emission TomographyProcessPublic HealthResistanceResolutionRoleSerotoninSignal TransductionSpecificitySymptomsSystemTestingVirginiaaffective neurosciencearmawakebasecingulate cortexclinical research siteclinically significantdepressive symptomsfunctional magnetic resonance imaging/electroencephalographyin vivomachine learning algorithmnegative moodneurochemistryneuroimagingneurosurgerynew technologynovel therapeuticsrelating to nervous systemresponsesymptomatic improvementtemporal measurement
项目摘要
PROJECT SUMMARY
Serotonin and dopamine dysfunction have been long implicated in the pathophysiology of major depression.
However, to date, delineating the role of these neuromodulators in depression has largely and necessarily
relied on inference, with neuroimaging (including PET, fMRI, EEG) studies revealing responses in brain
regions associated with dopamine and serotonin release and medications targeting the dopaminergic and
serotoninergic systems improving symptoms for some individuals. In order to make significant advances in
understanding the neural underpinnings of depression and developing novel therapeutics for the disorder,
tracking neuromodulator responses quickly, accurately, and in vivo is required.
Recent advances allow exactly the unprecedented ability to track neuromodulator responses with high
temporal resolution and chemical specificity. Specifically, we are able to directly and simultaneously measure
dopamine and serotonin responses in awake humans with the temporal resolution (~ 10 ms) required to
examine the relationship of neuromodulator release with decision-making processes. The product of these
advances is recordings of in vivo neuromodulator fluctuations at sub-second resolution. This application
merges the clinical and affective neuroscience expertise of MPI Chiu with these advances of MPI Montague to
directly examine the relationship of dopamine and serotonin responses to depression.
To achieve this goal, we will record neuromodulator responses in participants with medication-resistant
epilepsy who already have intracranial depth electrodes in place for phase-II monitoring. The depth electrodes
are implanted by our neurosurgery colleagues at Virginia Tech’s medical affiliate Carilion Clinic (Project Co-I
Witcher; Carilion Clinic clinical site PI). During recording, participants will be in a standard (i.e., non-surgical)
hospital monitoring suite and perform i) an affective processing task (emotional Stroop) and ii) a value-based
learning task (two-arm bandit) that have been shown by our group and others both to engage processes
thought to be related to serotonin and dopamine function, and also to be related to negative mood and
anhedonia symptoms, respectively, of depression.
项目概要
血清素和多巴胺功能障碍长期以来一直与重度抑郁症的病理生理学有关。
然而,迄今为止,描述这些神经调节剂在抑郁症中的作用在很大程度上也是必然的。
依赖于推理,神经影像(包括 PET、功能磁共振成像、脑电图)研究揭示了大脑的反应
与多巴胺和血清素释放相关的区域以及针对多巴胺能和血清素的药物
血清素能系统改善某些人的症状,以取得重大进展。
了解抑郁症的神经基础并开发针对该疾病的新疗法,
需要在体内快速、准确地跟踪神经调节剂的反应。
最近的进展使得追踪神经调节剂反应的能力达到前所未有的高度
具体来说,我们能够直接并同时测量。
清醒人类的多巴胺和血清素反应具有所需的时间分辨率(约 10 毫秒)
检查神经调节剂释放与决策过程的关系。
该应用的进展是以亚秒分辨率记录体内神经调节剂波动。
将 MPI Chiu 的临床和情感神经科学专业知识与 MPI Montague 的这些进步相结合,
直接检查多巴胺和血清素反应与抑郁症的关系。
为了实现这一目标,我们将记录耐药参与者的神经调节剂反应
已安装颅内深度电极进行第二阶段监测的癫痫患者。
由弗吉尼亚理工大学医疗附属机构 Carilion Clinic(Project Co-I)的神经外科同事植入
Witcher;Carilion Clinic 临床现场 PI) 在录制期间,参与者将处于标准状态(即非手术)。
医院病房监控并执行 i) 情感处理任务(情感 Stroop)和 ii) 基于价值的任务
我们的小组和其他人都证明了学习任务(双臂强盗)都参与了流程
据认为与血清素和多巴胺功能有关,也与消极情绪和
快感缺失症状分别为抑郁症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PEARL H CHIU其他文献
PEARL H CHIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PEARL H CHIU', 18)}}的其他基金
Sub-second neurochemistry of error signals and affective processing in depression
抑郁症中错误信号和情感处理的亚秒神经化学
- 批准号:
10665721 - 财政年份:2022
- 资助金额:
$ 75.09万 - 项目类别:
Social influences on choices in adolescent substance use
社会对青少年物质使用选择的影响
- 批准号:
10378098 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Evaluating overlap and distinctiveness in neurocomputational loss and reward elements of the RDoC matrix
评估 RDoC 矩阵的神经计算损失和奖励元素的重叠和独特性
- 批准号:
10455059 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Social influences on choices in adolescent substance use
社会对青少年物质使用选择的影响
- 批准号:
10552640 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Evaluating overlap and distinctiveness in neurocomputational loss and reward elements of the RDoC matrix
评估 RDoC 矩阵的神经计算损失和奖励元素的重叠和独特性
- 批准号:
10312509 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Making connections among social ties, neural sensitivity to social signals, and outcomes
在社会关系、对社会信号的神经敏感性和结果之间建立联系
- 批准号:
10629370 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Making connections among social ties, neural sensitivity to social signals, and outcomes
在社会关系、社会信号的神经敏感性和结果之间建立联系
- 批准号:
10490468 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Evaluating overlap and distinctiveness in neurocomputational loss and reward elements of the RDoC matrix
评估 RDoC 矩阵的神经计算损失和奖励元素的重叠和独特性
- 批准号:
10647805 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Making connections among social ties, neural sensitivity to social signals, and outcomes
在社会关系、对社会信号的神经敏感性和结果之间建立联系
- 批准号:
10200497 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
Social influences on choices in adolescent substance use
社会对青少年物质使用选择的影响
- 批准号:
10220529 - 财政年份:2021
- 资助金额:
$ 75.09万 - 项目类别:
相似国自然基金
序列预测及小脑在精神分裂症快感缺失中的作用及机制研究
- 批准号:32371143
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
精神分裂症快感缺失的神经机制及其干预:基于嗅觉的新视角
- 批准号:82371561
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于快感缺失功能影像特征构建抑郁症复发预测模型
- 批准号:82371531
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
甜味受体T1R2调节基底外侧杏仁核-伏隔核神经环路在抑郁症快感缺失中的作用研究
- 批准号:82304473
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Lcn2-24p3R通路参与抑郁症快感缺失的机制研究
- 批准号:82371530
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Determining the role of social reward learning in social anhedonia in first-episode psychosis using motivational interviewing as a probe in a perturbation-based neuroimaging approach
使用动机访谈作为基于扰动的神经影像学方法的探索,确定社交奖励学习在首发精神病社交快感缺乏中的作用
- 批准号:
10594181 - 财政年份:2023
- 资助金额:
$ 75.09万 - 项目类别:
Determining the role of social reward learning in social anhedonia in first-episode psychosis using motivational interviewing as a probe in a perturbation-based neuroimaging approach
使用动机访谈作为基于扰动的神经影像学方法的探索,确定社交奖励学习在首发精神病社交快感缺乏中的作用
- 批准号:
10594181 - 财政年份:2023
- 资助金额:
$ 75.09万 - 项目类别:
Assessment of approach-avoidance motivation in neuropsychiatric disorders
神经精神疾病的接近-回避动机评估
- 批准号:
10503869 - 财政年份:2022
- 资助金额:
$ 75.09万 - 项目类别:
Sub-second neurochemistry of error signals and affective processing in depression
抑郁症中错误信号和情感处理的亚秒神经化学
- 批准号:
10665721 - 财政年份:2022
- 资助金额:
$ 75.09万 - 项目类别:
Muscarinic modulation of RDoC constructs in primate behavior and fronto-striatal circuits
灵长类行为和额纹状体回路中 RDoC 结构的毒蕈碱调节
- 批准号:
10419231 - 财政年份:2022
- 资助金额:
$ 75.09万 - 项目类别: